Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer
Authors
Keywords
-
Journal
CELLULAR ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-05-29
DOI
10.1007/s13402-023-00824-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coadaptation fostered by the SLIT2-ROBO1 axis facilitates liver metastasis of pancreatic ductal adenocarcinoma
- (2023) Qing Li et al. Nature Communications
- Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment
- (2022) Yu-Heng Zhu et al. CELLULAR ONCOLOGY
- In vivo CD8+ T cell CRISPR screening reveals control by Fli1 in infection and cancer
- (2021) Zeyu Chen et al. CELL
- Transglutaminase 2 as a Marker for Inflammation and Therapeutic Target in Sepsis
- (2021) Ting Su et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Macrophage M2 Co-expression Factors Correlate With the Immune Microenvironment and Predict Outcome of Renal Clear Cell Carcinoma
- (2021) Yutao Wang et al. Frontiers in Genetics
- Neoadjuvant Cytoreductive Treatment with BRAF/MEK Inhibition of prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR
- (2021) Stéphanie A. Blankenstein et al. ANNALS OF SURGERY
- Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells
- (2021) Guangyan Kan et al. Advanced Science
- Transglutaminase 6 Is Colocalized and Interacts with Mutant Huntingtin in Huntington Disease Rodent Animal Models
- (2021) Anja Schulze-Krebs et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The physiology, pathology and potential therapeutic application of serotonylation
- (2021) Shu-Heng Jiang et al. JOURNAL OF CELL SCIENCE
- Molecular characteristics and tumorigenicity of ascites‐derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer
- (2021) Yi Ding et al. Molecular Oncology
- ELK3 Mediated by ZEB1 Facilitates the Growth and Metastasis of Pancreatic Carcinoma by Activating the Wnt/β-Catenin Pathway
- (2021) Qiuyan Zhao et al. Frontiers in Cell and Developmental Biology
- Coagulation Factor XIII Subunit A Is a Biomarker for Curative Effects and Prognosis in Malignant Solid Tumors, Especially Non-small Cell Lung Cancer
- (2021) Yujiao Luo et al. Frontiers in Oncology
- MAFB promotes cancer stemness and tumorigenesis in osteosarcoma through a Sox9-mediated positive feedback loop
- (2020) Yanyan Chen et al. CANCER RESEARCH
- Mass spectrum analysis of membrane proteins reveals that CASK, CD36 and EPB42 are differentially expressed in pancreatic adenocarcinoma
- (2020) Mingming Meng et al. Oncology Letters
- Transglutaminase 3: The Involvement in Epithelial Differentiation and Cancer
- (2020) Elina S. Chermnykh et al. Cells
- Emerging role of Fli1 in autoimmune diseases
- (2020) Yi-Sheng He et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Candidate genes involved in metastasis of colon cancer identified by integrated analysis
- (2019) Yiming Zhou et al. Cancer Medicine
- Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation
- (2019) Xiqiao Zhou et al. CELLULAR ONCOLOGY
- TGM3 promotes epithelial–mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection
- (2019) Jin-Wu Hu et al. DIGESTIVE AND LIVER DISEASE
- Zinc finger protein 365 is a new maternal LPS-binding protein that defends zebrafish embryos against gram-negative bacterial infections
- (2018) Xiaoyuan Du et al. FASEB JOURNAL
- Factor XIIIA—expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking
- (2018) Alessandro Porrello et al. Nature Communications
- Activation peptide of the coagulation factor XIII (AP-F13A1) as a new biomarker for the screening of colorectal cancer
- (2018) Julien Peltier et al. Clinical Proteomics
- Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice
- (2017) Shu-Heng Jiang et al. GASTROENTEROLOGY
- Elk-3 Contributes to the Progression of Liver Fibrosis by Regulating the Epithelial-Mesenchymal Transition
- (2017) Tian Zhu Li et al. Gut and Liver
- Ankyrin repeat and zinc-finger domain-containing 1 mutations are associated with infantile-onset inflammatory bowel disease
- (2017) Désirée Y. van Haaften-Visser et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Factor XIII Subunit A in the Skin: Applications in Diagnosis and Treatment
- (2017) Lilla Paragh et al. Biomed Research International
- The role of PRDMs in cancer: one family, two sides
- (2016) Slim Mzoughi et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Tissue transglutaminase-1 promotes stemness and chemoresistance in gastric cancer cells by regulating Wnt/β-catenin signaling
- (2016) Haitao Huang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Association between single nucleotide polymorphisms in prospective genes and susceptibility to ankylosing spondylitis and inflammatory bowel disease in a single centre in Turkey
- (2016) Orhan Kucuksahin et al. Turkish Journal of Gastroenterology
- A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer
- (2015) A. A. Adjei et al. CLINICAL CANCER RESEARCH
- FLI1 Levels Impact CXCR3 Expression and Renal Infiltration of T Cells and Renal Glycosphingolipid Metabolism in the MRL/lpr Lupus Mouse Strain
- (2015) Kamala P. Sundararaj et al. JOURNAL OF IMMUNOLOGY
- Allosteric MEK1/2 Inhibitor Refametinib (BAY 86-9766) in Combination with Sorafenib Exhibits Antitumor Activity in Preclinical Murine and Rat Models of Hepatocellular Carcinoma
- (2015) Roberta Schmieder et al. NEOPLASIA
- High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci
- (2014) Kwangwoo Kim et al. ANNALS OF THE RHEUMATIC DISEASES
- A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma
- (2014) H. Y. Lim et al. CLINICAL CANCER RESEARCH
- Tissue Transglutaminase Activation Modulates Inflammation in Cystic Fibrosis via PPAR Down-Regulation
- (2014) L. Maiuri et al. JOURNAL OF IMMUNOLOGY
- Overexpression of transglutaminase 4 and prostate cancer progression: a potential predictor of less favourable outcomes
- (2013) Zhi Cao et al. ASIAN JOURNAL OF ANDROLOGY
- Multicenter Phase I Trial of the Mitogen-Activated Protein Kinase 1/2 Inhibitor BAY 86-9766 in Patients with Advanced Cancer
- (2013) C. D. Weekes et al. CLINICAL CANCER RESEARCH
- TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells
- (2013) J. Fu et al. NEURO-ONCOLOGY
- Reducing FLI1 Levels in the MRL/lpr Lupus Mouse Model Impacts T Cell Function by Modulating Glycosphingolipid Metabolism
- (2013) Erin Morris Richard et al. PLoS One
- TGM5 Mutations Impact Epidermal Differentiation in Acral Peeling Skin Syndrome
- (2012) Manuela Pigors et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
- (2012) Jeffrey R Infante et al. LANCET ONCOLOGY
- Role of transglutaminase 2 in celiac disease pathogenesis
- (2012) Cornelius Klöck et al. Seminars in Immunopathology
- Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
- (2011) Tanios Bekaii-Saab et al. JOURNAL OF CLINICAL ONCOLOGY
- Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer
- (2011) L Cao et al. ONCOGENE
- Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells
- (2010) Anupam Kumar et al. PLoS One
- Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase
- (2009) M. Shao et al. CANCER RESEARCH
- Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma
- (2009) Ayako Negishi et al. CANCER SCIENCE
- Transglutaminases and Disease: Lessons From Genetically Engineered Mouse Models and Inherited Disorders
- (2009) Siiri E. Iismaa et al. PHYSIOLOGICAL REVIEWS
- A role for Fli-1 in B cell proliferation: Implications for SLE pathogenesis
- (2008) Sarah Bradshaw et al. CLINICAL IMMUNOLOGY
- Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function
- (2008) J. S. PALUMBO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started